Mast Cell Activation and Dysbiosis - Key Roles in Common GI Disorders
Functional gastrointestinal (GI) disorders such as irritable bowel syndrome and functional dyspepsia are thought to affect at least 15% of the general population. Mast cell activation and dysbiosis are among the leading pathophysiological processes that have been implicated in functional GI disorders featuring common symptoms such as bloating, abdominal pain, and altered bowel habits.
Advanced stool testing with quantitative PCR (qPCR) can provide important insights into overall gut health, as well as specific factors that may be involved in functional GI disorders.
Join Dr. Fabian as he discusses how GI-MAP stool testing can provide clinicians with critical insights into specific microbes, dysbiosis patterns, and GI imbalances that may contribute to mast cell activation and related symptoms in patients with functional GI disorders. Learn More about GI-MAP
Author Tom Fabian, Ph.D., CNTP
Dr. Fabian is a leading expert on the role of the microbiome in health, immune function, chronic disease, and aging. As a translational scientist, his primary focus is on the clinical application of microbiome research in the integrative and functional medicine space. He received his PhD in molecular biology from the University of Colorado, Boulder, and has worked as a biomedical researcher in the biotechnology industry...
The opinions expressed in this presentation are the author's own. Information is provided for informational purposes only and is not meant to be a substitute for personal advice provided by a doctor or other qualified health care professional. Patients should not use the information contained herein for diagnosing a health or fitness problem or disease. Patients should always consult with a doctor or other health care professional for medical advice or information about diagnosis and treatment.